These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 1633109)
1. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells. Bar-Ner M; Messing LT; Cultraro CM; Birrer MJ; Segal S Cell Growth Differ; 1992 Mar; 3(3):183-90. PubMed ID: 1633109 [TBL] [Abstract][Full Text] [Related]
2. Regulation of murine Max (Myn) parallels the regulation of c-Myc in differentiating murine erythroleukemia cells. Dunn BK; Cogliati T; Cultraro CM; Bar-Ner M; Segal S Cell Growth Differ; 1994 Aug; 5(8):847-54. PubMed ID: 7986749 [TBL] [Abstract][Full Text] [Related]
3. Functional domains of c-Myc involved in the commitment and differentiation of murine erythroleukemia cells. Ohmori Y; Tanabe J; Takada S; Lee WM; Obinata M Oncogene; 1993 Feb; 8(2):379-86. PubMed ID: 8426744 [TBL] [Abstract][Full Text] [Related]
4. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state. Chen J; Kremer CS; Bender TP Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of murine erythroleukemia cell differentiation by normal and partially deleted c-myc genes. Bar-Ner M; Messing LT; Segal S Immunobiology; 1992 Aug; 185(2-4):150-8. PubMed ID: 1452198 [TBL] [Abstract][Full Text] [Related]
7. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Prochownik EV; Kukowska J Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863 [TBL] [Abstract][Full Text] [Related]
8. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1. Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810 [TBL] [Abstract][Full Text] [Related]
9. Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells. Cogliati T; Dunn BK; Bar-Ner M; Cultraro CM; Segal S Oncogene; 1993 May; 8(5):1263-8. PubMed ID: 8479748 [TBL] [Abstract][Full Text] [Related]
10. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation. Min S; Mascarenhas NT; Taparowsky EJ Oncogene; 1993 Oct; 8(10):2691-701. PubMed ID: 8378081 [TBL] [Abstract][Full Text] [Related]
11. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation. Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709 [TBL] [Abstract][Full Text] [Related]
12. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. Koskinen PJ; Ayer DE; Eisenman RN Cell Growth Differ; 1995 Jun; 6(6):623-9. PubMed ID: 7669717 [TBL] [Abstract][Full Text] [Related]
13. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation. Suhasini M; Reddy CD; Reddy EP; DiDonato JA; Pilz RB Oncogene; 1997 Oct; 15(15):1859-70. PubMed ID: 9362453 [TBL] [Abstract][Full Text] [Related]
14. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643 [TBL] [Abstract][Full Text] [Related]
15. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation. Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254 [TBL] [Abstract][Full Text] [Related]
16. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells. Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression. Suhasini M; Boss GR; Pascual FE; Pilz RB Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161 [TBL] [Abstract][Full Text] [Related]
18. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells. Waga K; Nakamura Y; Maki K; Arai H; Yamagata T; Sasaki K; Kurokawa M; Hirai H; Mitani K Oncogene; 2003 Jan; 22(1):59-68. PubMed ID: 12527908 [TBL] [Abstract][Full Text] [Related]
19. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types. Prins J; De Vries EG; Mulder NH Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508 [TBL] [Abstract][Full Text] [Related]
20. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh. Naderi S; Blomhoff HK J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]